Article Information
History
- January 19, 2018.
Article Versions
- Version 1 (January 11, 2018 - 21:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rosemary C Challis1,
- Sripriya Ravindra Kumar1,
- Ken Y Chan1,
- Collin Challis1,
- Min J Jang1,
- Pradeep S Rajendran2,
- John D Tompkins2,
- Kalyanam Shivkumar2,
- Benjamin E Deverman1 and
- Viviana Gradinaru1,*
- 1Division of Biology and Biological Engineering, California Institute of Technology Pasadena, CA
- 2Cardiac Arrhythmia Center and Neurocardiology Research Center of Excellence, University of California, Los Angeles Los Angeles, CA
- ↵* To whom correspondence should be addressed: Viviana Gradinaru, Ph.D., Division of Biology and Biological Engineering, California Institute of Technology, 1200 East California Blvd. MC 156-29, Pasadena, CA 91125, Phone: (626) 395-6813, viviana{at}caltech.edu
Posted January 19, 2018.
Widespread and targeted gene expression by systemic AAV vectors: Production, purification, and administration
